Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hypersensitivity Reaction

  Free Subscription


Articles published in Eur Respir J

Retrieve available abstracts of 107 articles:
HTML format
Text format



Single Articles


    November 2018
  1. SINGH S, Collins BF, Bairwa M, Joshi JM, et al
    Hypersensitivity pneumonitis and its correlation with ambient air pollution in urban India.
    Eur Respir J. 2018 Nov 21. pii: 13993003.01563-2018.
    PubMed     Text format    


    June 2018
  2. SALISBURY ML, Gross BH, Chughtai A, Sayyouh M, et al
    Development and Validation of a Radiologic Diagnosis Model for Hypersensitivity Pneumonitis.
    Eur Respir J. 2018 Jun 25. pii: 13993003.00443-2018.
    PubMed     Text format     Abstract available


    April 2018
  3. OLIVEIRA RKF, Ota-Arakaki JS, Gomes PS, Gimenez A, et al
    Pulmonary haemodynamics and mortality in chronic hypersensitivity pneumonitis.
    Eur Respir J. 2018 Apr 5. pii: 13993003.00430-2018.
    PubMed     Text format    


    March 2018
  4. HUMBERT M, Taille C, Mala L, Le Gros V, et al
    Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study.
    Eur Respir J. 2018 Mar 15. pii: 13993003.02523-2017.
    PubMed     Text format     Abstract available


    February 2018
  5. HACCURIA A, Van Muylem A, Malinovschi A, Doan V, et al
    Small airways dysfunction: the link between allergic rhinitis and allergic asthma.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  6. SHAW D
    Putting the brake on accelerated lung function decline in asthma.
    Eur Respir J. 2018;51.
    PubMed     Text format    


    January 2018
  7. MOOKHERJEE N, Piyadasa H, Ryu MH, Rider CF, et al
    Inhaled diesel exhaust alters the allergen-induced bronchial secretome in humans.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  8. TONG X, Wang D, Liu S, Ma Y, et al
    Can YKL-40 be used as a biomarker and therapeutic target for adult asthma?
    Eur Respir J. 2018;51.
    PubMed     Text format    


  9. BEASLEY R, Braithwaite I, Fingleton J, Weatherall M, et al
    The inhaled corticosteroid/long-acting beta-agonist maintenance and reliever therapy regimen: where to from here?
    Eur Respir J. 2018;51.
    PubMed     Text format    


  10. GAGA M, Samitas K, Zervas E
    Inhaler adherence in severe asthma: is there an electronic solution?
    Eur Respir J. 2018;51.
    PubMed     Text format    


    December 2017
  11. SONG Y, Khoo SK, Lee KH, Makela M, et al
    Dual responses of CD14 methylation to distinct environments: a role in asthma and allergy.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  12. MORJARIA JB, Rigby AS, Morice AH
    Asthma phenotypes: do cough and wheeze predict exacerbations in persistent asthma?
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  13. MCDONALD VM, Yorke J
    Adherence in severe asthma: time to get it right.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  14. KOURI A, Boulet LP, Kaplan A, Gupta S, et al
    Asthma control and action plans.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  15. AMIRAV I, Newhouse MT
    Asthma control and action plans.
    Eur Respir J. 2017;50.
    PubMed     Text format    


    November 2017
  16. KOLEVA PT, Tun HM, Konya T, Guttman DS, et al
    Sex-specific impact of asthma during pregnancy on infant gut microbiota.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


    October 2017
  17. BOWATTE G, Erbas B, Lodge CJ, Knibbs LD, et al
    Traffic-related air pollution exposure over a 5-year period is associated with increased risk of asthma and poor lung function in middle age.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  18. GOMEZ JL, Yan X, Holm CT, Grant N, et al
    Characterisation of asthma subgroups associated with circulating YKL-40 levels.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  19. VAN DEN WIJNGAART LS, Roukema J, Boehmer ALM, Brouwer ML, et al
    A virtual asthma clinic for children: fewer routine outpatient visits, same asthma control.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  20. DUMAS O, Wiley AS, Quinot C, Varraso R, et al
    Occupational exposure to disinfectants and asthma control in US nurses.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  21. HEEDERIK D
    Occupational exposure and asthma control.
    Eur Respir J. 2017;50.
    PubMed     Text format    


    September 2017
  22. CLARKE R, Monaghan K, About I, Griffin CS, et al
    TRPA1 activation in a human sensory neuronal model: relevance to cough hypersensitivity?
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  23. FOSTER JM, McDonald VM, Guo M, Reddel HK, et al
    "I have lost in every facet of my life": the hidden burden of severe asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  24. FRICKER M, Gibson PG
    Macrophage dysfunction in the pathogenesis and treatment of asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  25. O'BYRNE PM, Jenkins C, Bateman ED
    The paradoxes of asthma management: time for a new approach?
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  26. HEKKING PP, Loza MJ, Pavlidis S, De Meulder B, et al
    Transcriptomic gene signatures associated with persistent airflow limitation in patients with severe asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  27. WENZEL SE, Brillhart S, Nowack K
    An invisible disease: severe asthma is more than just "bad asthma".
    Eur Respir J. 2017;50.
    PubMed     Text format    


  28. BUSH A, Pavord ID
    After the asthmas: Star Wars and Star Trek.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  29. ROBINSON DS, Kariyawasam HH, Heaney LG
    Phase three studies of biologics for severe asthma: could do better?
    Eur Respir J. 2017;50.
    PubMed     Text format    


  30. TO T, Zhu J, Carlsten C, Larsen K, et al
    Do community demographics, environmental characteristics and access to care affect risks of developing ACOS and mortality in people with asthma?
    Eur Respir J. 2017;50.
    PubMed     Text format    


    August 2017
  31. CHUPP G, Laviolette M, Cohn L, McEvoy C, et al
    Long-term outcomes of bronchial thermoplasty in subjects with severe asthma: a comparison of 3-year follow-up results from two prospective multicentre studies.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  32. PRETOLANI M, Soussan D, Poirier I, Thabut G, et al
    Clinical and biological characteristics of the French COBRA cohort of adult subjects with asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  33. MICHILS A, Haccuria A, Michiels S, Van Muylem A, et al
    Airway calibre variation is a major determinant of exhaled nitric oxide's ability to capture asthma control.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  34. THOMSON NC, Chanez P
    How effective is bronchial thermoplasty for severe asthma in clinical practice?
    Eur Respir J. 2017;50.
    PubMed     Text format    


  35. SIN DD, Leung JM, Wechsler ME
    Concern of underdiagnosing asthma-COPD overlap syndrome if age limit of 40 years for asthma is used.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  36. TOMMOLA M, Ilmarinen P, Tuomisto LE, Kankaanranta H, et al
    Concern of underdiagnosing asthma-COPD overlap syndrome if age limit of 40 years for asthma is used.
    Eur Respir J. 2017;50.
    PubMed     Text format    


    June 2017
  37. AL SALLAKH MA, Vasileiou E, Rodgers SE, Lyons RA, et al
    Defining asthma and assessing asthma outcomes using electronic health record data: a systematic scoping review.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  38. BERTHON BS, Gibson PG, Wood LG, MacDonald-Wicks LK, et al
    A sputum gene expression signature predicts oral corticosteroid response in asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  39. DUNICAN EM, Fahy JV
    Asthma and corticosteroids: time for a more precise approach to treatment.
    Eur Respir J. 2017;49.
    PubMed     Text format    


    May 2017
  40. EDWARDS MR, Saglani S, Schwarze J, Skevaki C, et al
    Addressing unmet needs in understanding asthma mechanisms: From the European Asthma Research and Innovation Partnership (EARIP) Work Package (WP)2 collaborators.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  41. COSIO BG, Perez de Llano L, Lopez Vina A, Torrego A, et al
    Th-2 signature in chronic airway diseases: towards the extinction of asthma-COPD overlap syndrome?
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  42. TOMMOLA M, Ilmarinen P, Tuomisto LE, Lehtimaki L, et al
    Differences between asthma-COPD overlap syndrome and adult-onset asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  43. KOURI A, Boulet LP, Kaplan A, Gupta S, et al
    An evidence-based, point-of-care tool to guide completion of asthma action plans in practice.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  44. THOMSON NC
    Asthma and smoking-induced airway disease without spirometric COPD.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  45. AZAD MB, Vehling L, Lu Z, Dai D, et al
    Breastfeeding, maternal asthma and wheezing in the first year of life: a longitudinal birth cohort study.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  46. BONTEN TN, Kasteleyn MJ, de Mutsert R, Hiemstra PS, et al
    Defining asthma-COPD overlap syndrome: a population-based study.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  47. SIMPSON AJ, Honkoop PJ, Kennington E, Snoeck-Stroband JB, et al
    Perspectives of patients and healthcare professionals on mHealth for asthma self-management.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  48. COATES AL, Wanger J, Cockcroft DW, Culver BH, et al
    ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  49. BERAIR R, Hartley R, Mistry V, Sheshadri A, et al
    Associations in asthma between quantitative computed tomography and bronchial biopsy-derived airway remodelling.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  50. YAN Q, Brehm J, Pino-Yanes M, Forno E, et al
    A meta-analysis of genome-wide association studies of asthma in Puerto Ricans.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  51. HTET TD, Teede HJ, de Courten B, Loxton D, et al
    Asthma in reproductive-aged women with polycystic ovary syndrome and association with obesity.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  52. MIRAVITLLES M
    Diagnosis of asthma-COPD overlap: the five commandments.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  53. MCDONALD VM, Gibson PG
    "To define is to limit": perspectives on asthma-COPD overlap syndrome and personalised medicine.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  54. HIMES BE, Ortega VE
    Making progress toward understanding the genetic architecture of asthma in the most affected US ethnic group.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  55. HERBERT C, Kumar RK
    Ambient air pollution and asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


    March 2017
  56. REINKE SN, Gallart-Ayala H, Gomez C, Checa A, et al
    Metabolomics analysis identifies different metabotypes of asthma severity.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  57. DEBRAY MP, Dombret MC, Pretolani M, Thabut G, et al
    Early computed tomography modifications following bronchial thermoplasty in patients with severe asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  58. GRAS D, Martinez-Anton A, Bourdin A, Garulli C, et al
    Human bronchial epithelium orchestrates dendritic cell activation in severe asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  59. MUNOZ-CANO R, Torrego A, Bartra J, Sanchez-Lopez J, et al
    Follow-up of patients with uncontrolled asthma: clinical features of asthma patients according to the level of control achieved (the COAS study).
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  60. BERGAUER A, Sopel N, Kross B, Vuorinen T, et al
    Rhinovirus species/genotypes and interferon-lambda: subtypes, receptor and polymorphisms - missing pieces of the puzzle of childhood asthma?
    Eur Respir J. 2017;49.
    PubMed     Text format    


  61. SCAGNOLARI C, Midulla F, Nenna R, Papoff P, et al
    Rhinovirus species/genotypes and interferon-lambda: subtypes, receptor and polymorphisms - missing pieces of the puzzle of childhood asthma?
    Eur Respir J. 2017;49.
    PubMed     Text format    


  62. BERGAUER A, Sopel N, Kross B, Vuorinen T, et al
    IFN-alpha/IFN-lambda responses to respiratory viruses in paediatric asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  63. STERK PJ
    A good asthma catch by professional fishing.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  64. BARALDO S, Papi A, Saetta M, Contoli M, et al
    IFN-alpha/IFN-lambda responses to respiratory viruses in paediatric asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


    February 2017
  65. ZOLLER B, Pirouzifard M, Memon AA, Sundquist J, et al
    Risk of pulmonary embolism and deep venous thrombosis in patients with asthma: a nationwide case-control study from Sweden.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  66. KUO CS, Pavlidis S, Loza M, Baribaud F, et al
    T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPRED.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  67. BRUMPTON B, Mai XM, Langhammer A, Laugsand LE, et al
    Prospective study of insomnia and incident asthma in adults: the HUNT study.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  68. PAPI A, Saetta M, Fabbri L
    Severe asthma: phenotyping to endotyping or vice versa?
    Eur Respir J. 2017;49.
    PubMed     Text format    


    January 2017
  69. ELLWOOD P, Asher MI, Billo NE, Bissell K, et al
    The Global Asthma Network rationale and methods for Phase I global surveillance: prevalence, severity, management and risk factors.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  70. GRIGG J
    Tiotropium in paediatric asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


    December 2016
  71. GAGA M, Zervas E, Humbert M
    Targeting immunoglobulin E in non-atopic asthma: crossing the red line?
    Eur Respir J. 2016;48:1538-1540.
    PubMed     Text format    


    November 2016
  72. BERGAUER A, Sopel N, Kross B, Vuorinen T, et al
    IFN-alpha/IFN-lambda responses to respiratory viruses in paediatric asthma.
    Eur Respir J. 2016 Nov 11. pii: ERJ-00969-2016. doi: 10.1183/13993003.00969-2016
    PubMed     Text format     Abstract available


  73. HAMELMANN E, Bernstein JA, Vandewalker M, Moroni-Zentgraf P, et al
    A randomised controlled trial of tiotropium in adolescents with severe symptomatic asthma.
    Eur Respir J. 2016 Nov 3. pii: ERJ-01100-2016. doi: 10.1183/13993003.01100-2016.
    PubMed     Text format     Abstract available


  74. LEZMI G, Galmiche-Rolland L, Rioux S, Jaubert F, et al
    Mast cells are associated with exacerbations and eosinophilia in children with severe asthma.
    Eur Respir J. 2016;48:1320-1328.
    PubMed     Text format     Abstract available


  75. WILSON SJ, Ward JA, Sousa AR, Corfield J, et al
    Severe asthma exists despite suppressed tissue inflammation: findings of the U-BIOPRED study.
    Eur Respir J. 2016;48:1307-1319.
    PubMed     Text format     Abstract available


  76. FLEMING L, Saglani S, Bush A
    Asthma attacks: should we nail our colours to the mast (cell)?
    Eur Respir J. 2016;48:1261-1264.
    PubMed     Text format    


    October 2016
  77. PILLAI P, Chan YC, Wu SY, Ohm-Laursen L, et al
    Omalizumab reduces bronchial mucosal IgE and improves lung function in non-atopic asthma.
    Eur Respir J. 2016 Oct 20. pii: ERJ-01501-2015. doi: 10.1183/13993003.01501-2015
    PubMed     Text format     Abstract available


  78. CAI Y, Zijlema WL, Doiron D, Blangiardo M, et al
    Ambient air pollution, traffic noise and adult asthma prevalence: a BioSHaRE approach.
    Eur Respir J. 2016 Oct 20. pii: ERJ-02127-2015. doi: 10.1183/13993003.02127-2015
    PubMed     Text format     Abstract available


  79. CHEN YC, Liou TH, Chen PC, Chiang BL, et al
    Growth trajectories and asthma/rhinitis in children: a longitudinal study in Taiwan.
    Eur Respir J. 2016 Oct 20. pii: ERJ-00741-2016. doi: 10.1183/13993003.00741-2016
    PubMed     Text format     Abstract available


  80. CHEN W, Lynd LD, FitzGerald JM, Marra CA, et al
    Excess medical costs in patients with asthma and the role of comorbidity.
    Eur Respir J. 2016 Oct 6. pii: ERJ-01141-2016. doi: 10.1183/13993003.01141-2016.
    PubMed     Text format     Abstract available


  81. MAGNUS MC, Haberg SE, Magnus P, Engeland A, et al
    Pre-eclampsia and childhood asthma.
    Eur Respir J. 2016 Oct 6. pii: ERJ-00673-2016. doi: 10.1183/13993003.00673-2016.
    PubMed     Text format     Abstract available


  82. SCHWARZE J, Fitch PM, Heimweg J, Errington C, et al
    Viral mimic poly-(I:C) attenuates airway epithelial T-cell suppressive capacity: implications for asthma.
    Eur Respir J. 2016 Oct 6. pii: ERJ-00841-2016. doi: 10.1183/13993003.00841-2016.
    PubMed     Text format    


  83. MAO B, Yang JW, Lu HW, Xu JF, et al
    Asthma and risk of bronchiectasis exacerbation: we still need more evidence.
    Eur Respir J. 2016;48:1247-1248.
    PubMed     Text format    


  84. GAO YH, Guan WJ, Chen RC, Zhang GJ, et al
    Asthma and risk of bronchiectasis exacerbation: we still need more evidence.
    Eur Respir J. 2016;48:1246-1247.
    PubMed     Text format    


  85. POYNTER ME, Irvin CG
    Interleukin-6 as a biomarker for asthma: hype or is there something else?
    Eur Respir J. 2016;48:979-981.
    PubMed     Text format    


  86. HAMBLETON K, Pavord ID
    What can we learn from blood granulocyte patterns in patients with asthma?
    Eur Respir J. 2016;48:976-978.
    PubMed     Text format    


    September 2016
  87. TOMMOLA M, Ilmarinen P, Tuomisto LE, Haanpaa J, et al
    The effect of smoking on lung function: a clinical study of adult-onset asthma.
    Eur Respir J. 2016 Sep 22. pii: ERJ-00850-2016. doi: 10.1183/13993003.00850-2016
    PubMed     Text format     Abstract available


  88. VAN DEN WIJNGAART LS, Roukema J, Merkus PJ
    Monitoring asthma: no matter how?
    Eur Respir J. 2016;48:614-6.
    PubMed     Text format    


  89. ROBINSON DS
    Assessing severe asthma.
    Eur Respir J. 2016;48:611-3.
    PubMed     Text format    


  90. GRAS D, Chanez P
    New sociology for better understanding severe eosinophilic asthma: introducing the SOCS family.
    Eur Respir J. 2016;48:608-10.
    PubMed     Text format    


  91. AHMADIZAR F, Vijverberg SJ, Arets HG, de Boer A, et al
    Childhood obesity in relation to poor asthma control and exacerbation: a meta-analysis.
    Eur Respir J. 2016 Sep 1. pii: ERJ-00766-2016. doi: 10.1183/13993003.00766-2016.
    PubMed     Text format     Abstract available


    August 2016
  92. ILMARINEN P, Tuomisto LE, Niemela O, Danielsson J, et al
    Comorbidities and elevated IL-6 associate with negative outcome in adult-onset asthma.
    Eur Respir J. 2016 Aug 18. pii: ERJ-02198-2015. doi: 10.1183/13993003.02198-2015
    PubMed     Text format     Abstract available


  93. LEHTIMAKI L, Csonka P, Makinen E, Isojarvi J, et al
    Predictive value of exhaled nitric oxide in the management of asthma: a systematic review.
    Eur Respir J. 2016 Aug 4. pii: ERJ-00699-2016. doi: 10.1183/13993003.00699-2016.
    PubMed     Text format     Abstract available


  94. NADIF R, Siroux V, Boudier A, le Moual N, et al
    Blood granulocyte patterns as predictors of asthma phenotypes in adults from the EGEA study.
    Eur Respir J. 2016 Aug 4. pii: ERJ-00336-2016. doi: 10.1183/13993003.00336-2016.
    PubMed     Text format     Abstract available


  95. KING GG, Thamrin C
    Complex lung function in severe asthma: seeing is believing.
    Eur Respir J. 2016;48:294-6.
    PubMed     Text format    


  96. PETERS MC, Fahy JV
    Metabolic consequences of obesity as an "outside in" mechanism of disease severity in asthma.
    Eur Respir J. 2016;48:291-3.
    PubMed     Text format    


  97. BARALDO S, Turato G, Cosio MG, Saetta M, et al
    Which CD8+ T-cells in asthma? Attacking or defending?
    Eur Respir J. 2016;48:287-90.
    PubMed     Text format    


    July 2016
  98. USEMANN J, Fuchs O, Anagnostopoulou P, Korten I, et al
    Predictive value of exhaled nitric oxide in healthy infants for asthma at school age.
    Eur Respir J. 2016 Jul 7. pii: ERJ-00439-2016. doi: 10.1183/13993003.00439-2016.
    PubMed     Text format    


    June 2016
  99. VAN DER MEER AN, Pasma H, Kempenaar-Okkema W, Pelinck JA, et al
    A 1-day visit in a severe asthma centre: effect on asthma control, quality of life and healthcare use.
    Eur Respir J. 2016 Jun 23. pii: ERJ-00220-2016. doi: 10.1183/13993003.00220-2016
    PubMed     Text format     Abstract available


  100. SIN DD, Miravitlles M, Mannino DM, Soriano JB, et al
    What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion.
    Eur Respir J. 2016 Jun 23. pii: ERJ-00436-2016. doi: 10.1183/13993003.00436-2016
    PubMed     Text format     Abstract available


  101. DORAN E, Choy DF, Shikotra A, Butler CA, et al
    Reduced epithelial suppressor of cytokine signalling 1 in severe eosinophilic asthma.
    Eur Respir J. 2016 Jun 23. pii: ERJ-00400-2015. doi: 10.1183/13993003.00400-2015
    PubMed     Text format     Abstract available


  102. FISHER JA, Puett RC, Hart JE, Camargo CA Jr, et al
    Particulate matter exposures and adult-onset asthma and COPD in the Nurses' Health Study.
    Eur Respir J. 2016 Jun 10. pii: ERJ-00845-2015. doi: 10.1183/13993003.00845-2015
    PubMed     Text format    


    May 2016
  103. DEN OTTER I, Willems LN, van Schadewijk A, van Wijngaarden S, et al
    Lung function decline in asthma patients with elevated bronchial CD8, CD4 and CD3 cells.
    Eur Respir J. 2016 May 26. pii: ERJ-01525-2015. doi: 10.1183/13993003.01525-2015
    PubMed     Text format     Abstract available


  104. VASBINDER EC, Goossens LM, Rutten-van Molken MP, de Winter BC, et al
    e-Monitoring of Asthma Therapy to Improve Compliance in children (e-MATIC): a randomised controlled trial.
    Eur Respir J. 2016 May 26. pii: ERJ-01698-2015. doi: 10.1183/13993003.01698-2015
    PubMed     Text format     Abstract available


  105. DUCHARME FM, Gagnon R, Benard B, Tse SM, et al
    Cessation of long-acting beta2-agonist in children with persistent asthma on inhaled corticosteroids.
    Eur Respir J. 2016 May 26. pii: ERJ-00014-2016. doi: 10.1183/13993003.00014-2016
    PubMed     Text format    


  106. SVENNINGSEN S, Nair P, Guo F, McCormack DG, et al
    Is ventilation heterogeneity related to asthma control?
    Eur Respir J. 2016 May 12. pii: ERJ-00393-2016. doi: 10.1183/13993003.00393-2016
    PubMed     Text format     Abstract available


  107. CHIH AH, Chen YC, Tu YK, Huang KC, et al
    Mediating pathways from central obesity to childhood asthma: a population-based longitudinal study.
    Eur Respir J. 2016 May 12. pii: ERJ-00226-2016. doi: 10.1183/13993003.00226-2016
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: